RNA Interference-based Therapies for the Reduction of Cardiovascular Risk

Natalia Nazarenko(Jacobi Medical Center), Damianos G. Kokkinidis(Memorial Hospital of South Bend), Jiyoung Seo(Albert Einstein College of Medicine), Leonidas Palaiodimos(Albert Einstein College of Medicine), Sanjana Nagraj(Jacobi Medical Center)

Current Molecular Pharmacology

February 29, 2024

10.2174/0118761429264553231204115314

Cited by 5

Related Papers

Severe obesity, increasing age and male sex are independently associated with worse in-hospital outcomes, and higher in-hospital mortality, in a cohort of patients with COVID-19 in the Bronx, New York

|Metabolism|2020|901

Assessment of Prognostic Value of Left Ventricular Global Longitudinal Strain for Early Prediction of Chemotherapy-Induced Cardiotoxicity

|JAMA Cardiology|2019|418

Atrial Fibrillation Is Associated with Cognitive Impairment, All-Cause Dementia, Vascular Dementia, and Alzheimer’s Disease: a Systematic Review and Meta-Analysis

|Journal of General Internal Medicine|2021|125

Management of venous thromboembolism in pregnancy

|Thrombosis Research|2022|91

The role and clinical implications of diastolic dysfunction in aortic stenosis

|Heart|2017|90